Clinical Trial Update: A Study to Assess the Safety and Efficacy of Vilaprisan in Japanese Subjects With Uterine Fibroids and Heavy Menstrual Bleeding [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and efficacy of vilaprisan in Japanese subjects with uterine fibroids and heavy menstrual bleeding; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heavy Menstrual Bleeding
• Uterine Fibroids

Drugs mentioned

• Vilaprisan (vilaprisan)

Snippet

Sponsor: Bayer | Conditions: Uterine Fibroids and Heavy Menstrual Bleeding | Phase 3 | Status: TERMINATED